Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Socrates E Papapoulos

Showing results (51-60 of 79) with videos related to

Pageof 8
Sort By:
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 17, 2005
Absorption of the oral bisphosphonate alendronate in osteoporotic patients with Crohn's diseaseSerge C L M Cremers, Ruud van Hogezand, Denise Bänffer, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 8, 2003
Relationships between pharmacokinetics and rate of bone turnover after intravenous bisphosphonate (olpadronate) in patients with Paget's disease of boneSerge C L M Cremers, Marelise E M W Eekhoff, Jan Den Hartigh, et al.
Journal of Clinical Medicine|August 29, 2024
Cyclical Etidronate Reduces the Progression of Arterial Calcifications in Patients with Pseudoxanthoma Elasticum: A 6-Year Prospective Observational StudyIris M Harmsen, Tim van den Beukel, Madeleine Kok, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 10, 2004
Paget's disease of bone in The Netherlands: a population-based radiological and biochemical survey--the Rotterdam StudyMarelise E M W Eekhoff, Marjolein van der Klift, Herman M Kroon, et al.
The Journal of Clinical Endocrinology and Metabolism|May 12, 2021
The Duration of Denosumab Treatment and the Efficacy of Zoledronate to Preserve Bone Mineral Density After Its DiscontinuationPolyzois Makras, Natasha M Appelman-Dijkstra, Socrates E Papapoulos, et al.
Breast Cancer Research and Treatment|March 5, 2004
Prognostic significance of periodic acid-Schiff-positive patterns in primary breast cancer and its lymph node metastasesJeroen T Buijs, Anne-Marie Cleton, Vincent T H B M Smit, et al.
The Journal of Clinical Endocrinology and Metabolism|September 29, 2005
Bone mineral density in sclerosteosis; affected individuals and gene carriersJessica C Gardner, Rutger L van Bezooijen, Benjamin Mervis, et al.
Plos One|November 7, 2015
Nasal Levels of Antimicrobial Peptides in Allergic Asthma Patients and Healthy Controls: Differences and Effect of a Short 1,25(OH)2 Vitamin D3 TreatmentWillemien Thijs, Kirsten Janssen, Annemarie M van Schadewijk, et al.
Bone|November 19, 2003
Determinants of induction and duration of remission of Paget's disease of bone after bisphosphonate (olpadronate) therapyMarelise E M W Eekhoff, Aeilko H Zwinderman, Dorien M A D Haverkort, et al.
Endocrinology|March 19, 2002
Bone morphogenetic proteins stimulate angiogenesis through osteoblast-derived vascular endothelial growth factor AMartine M L Deckers, Rutger L van Bezooijen, Geertje van der Horst, et al.
Pageof 8

Showing results (51-60 of 79) with videos related to

Sort By:
Pageof 8
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 17, 2005
Absorption of the oral bisphosphonate alendronate in osteoporotic patients with Crohn's diseaseSerge C L M Cremers, Ruud van Hogezand, Denise Bänffer, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 8, 2003
Relationships between pharmacokinetics and rate of bone turnover after intravenous bisphosphonate (olpadronate) in patients with Paget's disease of boneSerge C L M Cremers, Marelise E M W Eekhoff, Jan Den Hartigh, et al.
Journal of Clinical Medicine|August 29, 2024
Cyclical Etidronate Reduces the Progression of Arterial Calcifications in Patients with Pseudoxanthoma Elasticum: A 6-Year Prospective Observational StudyIris M Harmsen, Tim van den Beukel, Madeleine Kok, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 10, 2004
Paget's disease of bone in The Netherlands: a population-based radiological and biochemical survey--the Rotterdam StudyMarelise E M W Eekhoff, Marjolein van der Klift, Herman M Kroon, et al.
The Journal of Clinical Endocrinology and Metabolism|May 12, 2021
The Duration of Denosumab Treatment and the Efficacy of Zoledronate to Preserve Bone Mineral Density After Its DiscontinuationPolyzois Makras, Natasha M Appelman-Dijkstra, Socrates E Papapoulos, et al.
Breast Cancer Research and Treatment|March 5, 2004
Prognostic significance of periodic acid-Schiff-positive patterns in primary breast cancer and its lymph node metastasesJeroen T Buijs, Anne-Marie Cleton, Vincent T H B M Smit, et al.
The Journal of Clinical Endocrinology and Metabolism|September 29, 2005
Bone mineral density in sclerosteosis; affected individuals and gene carriersJessica C Gardner, Rutger L van Bezooijen, Benjamin Mervis, et al.
Plos One|November 7, 2015
Nasal Levels of Antimicrobial Peptides in Allergic Asthma Patients and Healthy Controls: Differences and Effect of a Short 1,25(OH)2 Vitamin D3 TreatmentWillemien Thijs, Kirsten Janssen, Annemarie M van Schadewijk, et al.
Bone|November 19, 2003
Determinants of induction and duration of remission of Paget's disease of bone after bisphosphonate (olpadronate) therapyMarelise E M W Eekhoff, Aeilko H Zwinderman, Dorien M A D Haverkort, et al.
Endocrinology|March 19, 2002
Bone morphogenetic proteins stimulate angiogenesis through osteoblast-derived vascular endothelial growth factor AMartine M L Deckers, Rutger L van Bezooijen, Geertje van der Horst, et al.
Pageof 8